AXIOS June 4, 2024
Tina Reed

The evidence of new obesity and diabetes drugs’ smashing success can now be seen in grocery store aisles.

Why it matters: Food giants are rolling out new and reformulated products appealing to the changing appetites of the fast-growing number of people prescribed drugs like Novo Nordisk’s Ozempic and Wegovy — and experts say this could shift American diets more broadly.

The big picture: It’s thought the drugs known as GLP-1 agonists help patients lose weight by slowing down stomach emptying, allowing them to get full faster and for longer.

  • But that can also make it harder to get necessary nutrients, experts say.
  • GLP-1 users also have reported changing tastes, with high-fat and sweet foods becoming less appealing for some.
  • ...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Retailer
Walmart is 1st retailer to deliver Rx, general products together
Healthcare CEOs: No time to underestimate retail healthcare
Walmart and Amazon Turn to GenAI and Ditch the ‘Search’ Bar
Walmart bets on multiple AI models with new Wallaby LLM
Walmart Expands Centers of Excellence Benefit To Include All Cancers

Share This Article